Doctor taking notes

Resources

Publications

Nov 2018
A 14-Day Intravenous Infusion Toxicity and Toxicokinetic Study of DUR-928, a Novel, First in Class, Investigational Therapeutic in Sprague-Dawley Rats 
Linval DePass, Andrew Miksztal, Ethan Bui, Hongwei Wu, Cedric Gordon, and WeiQi Lin | American College of Toxicology
Oct 2018
Attenuation of Renal Ischemic Reperfusion Injury in Rats with DUR-928, a Novel, First-in-Class Therapeutic in Development for Renal Disease 
Mee J. Kim, Hongwei Wu, and WeiQi Lin | American Society of Nephrology annual Kidney Week meeting
Oct 2018
Safety and Single Ascending Dose Pharmacokinetic Study of DUR-928 in Patients with Chronic Kidney Disease versus Matched Control Subjects
Jaymin Shah, Dave Ellis, Andrew Miksztal, and WeiQi Lin | American Society of Nephrology annual Kidney Week meeting
Sep 2018
A Clinical Drug-Drug Interaction Study with Midazolam to Assess the Effect of DUR-928 on CYP3A4 
Jaymin Shah, Gwenaelle Mille, Andrew Miksztal, and WeiQi Lin | American College of Clinical Pharmacology
Mar 2018
In Vivo Tissue Distribution and Elimination of DUR-928, a First in Class Therapeutic for Treatment of Hepatic and Renal Disease 
Linval DePass, Jaymin Shah, Andrew Miksztal, and WeiQi Lin | Society of Toxicology Annual Meeting

Factsheets

See the resources included here for more information and resources from DURECT.

Scroll to Top